Form D Explorer

Form 1-K — Nok Therapeutics, Inc.

0001213900-25-040030 · filed 2025-05-06

Offering

Total offering: —
Total sold: —
Security type: —
Price per security: —
Over-allotment: —
Jurisdictions: —

Issuer

Name: Nok Therapeutics, Inc.
CIK: 2038166
Entity: Corporation
Jurisdiction: FLORIDA
Address: 2009 MACKENZIE WAY
CRANBERRY TWP., PA 16066

Most recent fiscal year financials

Reg A+ Tier 2 financials are audited (1-A, 1-K). Tier 1 are reviewed.

Total assets

—

Total liabilities

—

Cash

—

Total revenues

—

Net income

—

Same issuer's Form D filings

D · 2026-04-22
D · 2026-04-22

$1.4K
D · 2026-04-22

$750K
D · 2026-03-26

$1.4K
D · 2025-10-24

$750K
D · 2025-10-24

View original on SEC EDGAR.